4.6 Editorial Material

Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT

Journal

CLINICAL NUCLEAR MEDICINE
Volume 46, Issue 4, Pages E231-E232

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000003347

Keywords

F-18-fluciclovine; Ga-68-PSMA-11; prostate cancer; oligodendroglioma; brain tumors; PET/CT

Ask authors/readers for more resources

Prostate cancer is a common cancer in men with high recurrence rate, and Ga-68-PSMA-11 and F-18-fluciclovine are PET imaging tracers used to detect recurrence sites. In a case study, an 83-year-old man with known oligodendroglioma and biochemically recurrent PC showed high focal uptake of Ga-68-PSMA-11 and F-18-fluciclovine in the brain.
Prostate cancer (PC) is one of the most common cancers affecting men worldwide, with a high recurrence rate after therapy. Ga-68-PSMA-11 and F-18-fluciclovine are PET imaging tracers for the detection of recurrence sites in PC patients. Ga-68-PSMA-11 is a membrane antigen overexpressed by tumor cells, whereas F-18-fluciclovine targets increased amino acid transporter in the membrane of cancer cells. We report a case of an 83-year-old man with known oligodendroglioma and biochemically recurrent PC who shows a high focal Ga-68-PSMA-11 and F-18-fluciclovine uptake in the brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available